APA (7th ed.) Citation

Christophi, G. P., Christophi, J. A., Gruber, R. C., Mihai, C., Mejico, L. J., Massa, P. T., & Jubelt, B. (2011). Quantitative differences in the immunomodulatory effects of Rebif and Avonex in IFN-β 1a treated multiple sclerosis patients. Journal of the neurological sciences, 307(1-2), 41-45. https://doi.org/10.1016/j.jns.2011.05.024

Chicago Style (17th ed.) Citation

Christophi, George P., Jennifer A. Christophi, Ross C. Gruber, Cornelia Mihai, Luis J. Mejico, Paul T. Massa, and Burk Jubelt. "Quantitative Differences in the Immunomodulatory Effects of Rebif and Avonex in IFN-β 1a Treated Multiple Sclerosis Patients." Journal of the Neurological Sciences 307, no. 1-2 (2011): 41-45. https://doi.org/10.1016/j.jns.2011.05.024.

MLA (9th ed.) Citation

Christophi, George P., et al. "Quantitative Differences in the Immunomodulatory Effects of Rebif and Avonex in IFN-β 1a Treated Multiple Sclerosis Patients." Journal of the Neurological Sciences, vol. 307, no. 1-2, 2011, pp. 41-45, https://doi.org/10.1016/j.jns.2011.05.024.